Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-26 @ 3:19 AM
Study NCT ID:
NCT03771820
Status:
UNKNOWN
Last Update Posted:
2021-03-17
First Post:
2018-11-01
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen
Sponsor:
NanoCarrier Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2021-04-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-04-30
Completion Date Type:
ESTIMATED
First Submit Date:
2018-11-01
First Submit QC Date:
None
Study First Post Date:
2018-12-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-15
Last Update Post Date:
2021-03-17
Last Update Post Date Type:
ACTUAL